Study S000717

Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways): A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06221696
Acronym: PWR-FAST
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: COMPLETED
Enrollment: 160
Start: 2023-06-12
Primary completion: 2023-11-23
Lead sponsor: S.LAB (SOLOWAYS)
Conditions: Overweight and Obesity
Interventions: DIETARY_SUPPLEMENT:Active Fiber Supplement Group; OTHER:Placebo Group
Results posted: FALSE

Registered primary outcomes

Percentage of weight regain from baseline [180 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.